DCF — MCLEOD HEALTH CHERAW
Enterprise Value: $-4.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-4.7M
Enterprise Value
$-2.9M
PV of Cash Flows
$-1.8M
PV of Terminal Value
$-2.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $56.4M | $0.9M | 2.0% | $-1.5M | $-1.3M |
| Year 2 | $58.1M | $1.5M | 3.0% | $-1.0M | $-0.8M |
| Year 3 | $59.8M | $2.2M | 4.0% | $-0.5M | $-0.4M |
| Year 4 | $61.6M | $2.5M | 4.0% | $-0.3M | $-0.2M |
| Year 5 | $63.5M | $2.8M | 4.0% | $-0.2M | $-0.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-4.7M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$54.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.011206301279333523
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5